Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Asberry

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Gene Therapy|April 15, 2021
PRMT5: a putative oncogene and therapeutic target in prostate cancerElena Beketova, Jake L Owens, Andrew M Asberry, et al.
Iscience|December 30, 2019
PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair GenesJake L Owens, Elena Beketova, Sheng Liu, et al.
Journal of Medicinal Chemistry|October 7, 2022
Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction InhibitorsAndrew M Asberry, Xinpei Cai, Xuehong Deng, et al.
Cancer Research|October 1, 2020
Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate CancerElena Beketova, Shuyi Fang, Jake L Owens, et al.
Molecular Cancer Therapeutics|January 14, 2022
Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to RadiationJake L Owens, Elena Beketova, Sheng Liu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Gene Therapy|April 15, 2021
PRMT5: a putative oncogene and therapeutic target in prostate cancerElena Beketova, Jake L Owens, Andrew M Asberry, et al.
Iscience|December 30, 2019
PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair GenesJake L Owens, Elena Beketova, Sheng Liu, et al.
Journal of Medicinal Chemistry|October 7, 2022
Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction InhibitorsAndrew M Asberry, Xinpei Cai, Xuehong Deng, et al.
Cancer Research|October 1, 2020
Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate CancerElena Beketova, Shuyi Fang, Jake L Owens, et al.
Molecular Cancer Therapeutics|January 14, 2022
Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to RadiationJake L Owens, Elena Beketova, Sheng Liu, et al.
Pageof 1